Patents by Inventor Clement Rioux

Clement Rioux has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cloning and expression of Haemophilus somnus transferrin-binding proteins
    Publication number: 20030007981
    Abstract: Cloning and expression of genes encoding H. somnus transferrin-binding proteins are described. The transferrin-binding proteins can be used in vaccine compositions for the prevention and treatment of H. somnus infections, as well as in diagnostic methods for determining the presence of H. somnus infections.
    Type: Application
    Filed: March 13, 2002
    Publication date: January 9, 2003
    Applicant: University of Saskatchewan
    Inventors: Andrew A. Potter, Clement Rioux, Anthony B. Schryvers
  • Vaccine compositions comprising Haemophilus somnus transferrin-binding proteins and methods of use
    Patent number: 6391316
    Abstract: Cloning and expression of genes encoding H. somnus transferrin-binding proteins are described. The transferrin-binding proteins can be used in vaccine compositions for the prevention and treatment of H. somnus infections, as well as in diagnostic methods for determining the presence of H. somnus infections.
    Type: Grant
    Filed: September 24, 1999
    Date of Patent: May 21, 2002
    Assignee: University of Saskatchewan
    Inventors: Andrew A. Potter, Clement Rioux, Anthony B. Schryvers
  • Proteinase K resistant surface protein of neisseria meningitidis
    Patent number: 6287574
    Abstract: A highly conserved, immunologically accessible antigen at the surface of Neisseria meningitidis organisms. Immunotherapeutic, prophylactic and diagnostic compositions and methods useful in the treatment, prevention an diagnosis of Neisseria meningitidis diseases. A proteinase K resistant Neisseria meningitidis surface protein having an apparent molecular weight of 22 kDa, the corresponding nucleotide and derived amino acid sequences (SEQ ID NO: 1, NO:3, NO:5 and NO:7: SEQ ID NO: 2, NO:4, NO:6, and NO:8), recombinant DNA methods for the production of the Neisseria meningitidis 22 kDA surface protein, and antibodies that bind to the Neisseria meningitidis 22 kDA surface protein.
    Type: Grant
    Filed: November 13, 1997
    Date of Patent: September 11, 2001
    Assignee: BioChem Pharma Inc.
    Inventors: Bernard R. Brodeur, Denis Martin, Josee Hamel, Clement Rioux